Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Allarity Therapeutics Inc...

    NASDAQ: ALLR · Real-Time Price · USD
    0.83
    -0.00 (-0.49%)
    At close: Jun 17, 2025, 3:02 PM

    Allarity Therapeutics Statistics

    Share Statistics

    Allarity Therapeutics has 15.08M shares outstanding. The number of shares has increased by -82.67% in one year.

    Shares Outstanding

    n/a
    		 15.08M

    Shares Change (YoY)

    n/a
    		 -82.67%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 19.14%

    Shares Floating

    n/a
    		 11.53M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 1.05M, so 6.94% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.05M

    Short % of Shares Out

    n/a
    		 6.94%

    Short % of Float

    n/a
    		 6.94%

    Short Ratio (days to cover)

    n/a
    		 1.63

    Valuation Ratios

    The PE ratio is -0.08 and the forward PE ratio is -0.02. Allarity Therapeutics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.08

    Forward PE

    n/a
    		 -0.02

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.16

    P/FCF Ratio

    n/a
    		 -0.1

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Allarity Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.11.

    Current Ratio

    n/a
    		 2.06

    Quick Ratio

    n/a
    		 2.06

    Debt / Equity

    n/a
    		 0.11

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 41.72

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-4,085,833.33

    Employee Count

    n/a
    		 6

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -381K

    Effective Tax Rate

    n/a
    		 1.53%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is -0.15, so Allarity Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.15

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.95

    200-Day Moving Average

    n/a
    		 1.38

    Relative Strength Index (RSI)

    n/a
    		 41.05

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -27.24M

    Net Income

    n/a
    		 -24.52M

    EBITDA

    n/a
    		 -27.24M

    EBIT

    n/a
    		 -25.55M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 19.53M in cash and 1.35M in debt, giving a net cash position of 18.18M.

    Cash & Cash Equivalents

    n/a
    		 19.53M

    Total Debt

    n/a
    		 1.35M

    Net Cash

    n/a
    		 18.18M

    Retained Earnings

    n/a
    		 -118.97M

    Total Assets

    n/a
    		 29.73M

    Working Capital

    n/a
    		 18.36M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -17.35M and capital expenditures -298K, giving a free cash flow of -17.65M.

    Operating Cash Flow

    n/a
    		 -17.35M

    Capital Expenditures

    n/a
    		 -298K

    Free Cash Flow

    n/a
    		 -17.65M

    FCF Per Share

    n/a
    		 -11.2
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ALLR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ALLR.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 11, 2024. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Sep 11, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -6.89

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist